Cryptococcal Meningoencephalitis in HIV/AIDS: When to Start Antiretroviral Therapy?

Annals of Clinical Microbiology and Antimicrobials - United Kingdom
doi 10.1186/s12941-017-0184-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

When to Start Antiretroviral Therapy During Tuberculosis Treatment?

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2013English

Cryptococcal Meningoencephalitis.

BMJ
1975English

When to Start ART? A Replication Study of Timing of Antiretroviral Therapy for HIV-1-associated Tuberculosis

2018English

Psychological Problems of HIV-infected Patients in Preparing to the Start of Antiretroviral Therapy

Jurnal Infektologii
Infectious Diseases
2019English

Time to Death Predictors of HIV/AIDS Infected Patients on Antiretroviral Therapy in Ethiopia

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2018English

Brain MRI Findings in Cryptococcal Meningoencephalitis

Journal of Nippon Medical School
Medicine
2000English

The Evaluation of Virological and Immunological Response to Antiretroviral Therapy in HIV/AIDS Cases

Ankem Dergisi
2012English

Prevalence of Cryptococcal Antigenemia and Associated Factors Among HIV/AIDS Patients on Second-Line Antiretroviral Therapy at Two Hospitals in Western Oromia, Ethiopia

PLoS ONE
Multidisciplinary
2019English

Earlier Versus Later Start of Antiretroviral Therapy in HIV-Infected Adults With Tuberculosis

New England Journal of Medicine
Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy